Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial

Table 3

Percentage of patients’ satisfaction in both groups during treatment and follow-up.

Treatment method	Pimecrolimus	Combination of microneedling and pimecrolimus				Fischer’s exact test
Patients’ satisfaction	Ultralow	Ultralow	Low	Moderate	High
After 2 weeks	15 (100%)	14 (93.3%)	0 (0%)	1 (6.7%)	0 (0%)	0.999
After 1 month	15 (100%)	13 (86.6%)	1 (6.7%)	1 (6.7%)	0 (0%)	0.762
After 45 days	15 (100%)	10 (6.66%)	1 (6.7%)	4 (26.7%)	0 (0%)	0.035
After 2 months	15 (100%)	9 (60%)	1 (6.7%)	5 (33.3%)	0 (0%)	0.019
After 75 days	15 (100%)	6 (40%)	0 (0%)	7 (46.6%)	2 (13.4%)	<0.001
After 3 months	15 (100%)	6 (40%)	0 (0%)	4 (26.7%)	5 (33.3%)	<0.001
After 6 months’ follow-up	15 (100%)	6 (40%)	0 (0%)	4 (26.7%)	5 (33.3%)	<0.001
Friedman test	-	<0.001